Recent News

MARYLAND HEIGHTS, MO  August 21, 2015 / Lee Biosolutions Inc. is a global biotech company producing highly purified enzymes and proteins that are used in research and commercial clinical diagnostic applications. The combination of increased capabilities with our new 41,000 square foot state-of-the-art Maryland Heights research and manufacturing facility and the scientific team's extensive expertise with protein purification has led to increased growth opportunities for the company in areas of endocrine, inflammation, coagulation, oncology, cardiovascular and autoimmune disease markets.

Burton Lee, CEO explained, "By strategically increasing our investment in research and manufacturing capabilities and expanding partnerships with our clients, we have carved out a successful business in the world-wide scientific community. We have developed some of the most successful purification processes in the industry and have been key suppliers to all major diagnostic companies and innovative clients such as St. Teresa Medical."

Lee Biosolutions stands out in the industry because of its historical manufacturing experience in mammalian tissues and serum protein extraction, purification and isolation. The company can tailor the purification, development, process chromatography and protein characterization to ensure our clients obtain the right product for their final application.

About Lee Biosolutions, Inc.:

We are headquartered in a 41,000 square feet state of the art cGMP-compliant facility in Maryland Heights, MO. Lee Biosolutions is a certified, licensed ISO, FDA, EPA and USDA leader in process development and bulk manufacturing of high quality purified enzymes and related proteins for research and clinical diagnostic tests. Lee Biosolutions products are used for such pathologies as cardiac disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders.

Lee Biosolutions is a healthcare biotech company that manufactures finished proteins for the research and clinical diagnostic and life science market.Today we are proud to announce the promotion of Matthew Lee as President and Chief Operating Officer.  Burton Lee will maintain his role as CEO and focus on strategic planning.

Burton Lee, Chief Executive Officer of Lee Biosolutions stated, " Matt’s leadership skills and business acuity has helped us maintain double digit growth and increased profitability allowing us to expand our operations. His dedication to our team, vendors and customers has made this management move as the most logical choice in order to maximize our potential for growth.”  

Matthew Lee holds a B.S. in Marketing Management from Missouri State University and joined Lee Biosolutions in 2012 as Logistics Manager. He was promoted to Vice-President of Business Operations in 2014 for his ability to improve operational efficiencies in the business. He is currently on the Board of Directors and not only continue running the day to day operations but will assist the CEO in applying creative solutions to strategic challenges.

About Lee Biosolutions, Inc.

We are a global healthcare biotech company that specializes in process development and bulk manufacturing of finished human and animal enzymes and related proteins for research and clinical diagnostic tests. Our products are used for such pathologies as cardiac disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders. Our expertise includes process optimization and scale-up, bioanalytical development, validation and purification of biologicals. We are known for our ability to take a bench top pilot process and scale up to commercialization that is efficient and cost effective for our clients.

To Whom It May Concern,

We are pleased to announce that we will officially move to a larger facility on August 10^th.Please amend your records to our new contact details.

New Physical Address:

Lee Biosolutions, Inc.10850 Metro Ct, Maryland Heights, MO 63043

New Mailing Address:

Lee Biosolutions, IncPO Box 1569, Maryland Heights, MO 63043

Our new 41,000 sq. Ft facility will allow us to meet our growth projections by tripling our capacity, adding new employees and providing better service to our customers and vendors. We will not accept any deliveries to our old facility at 2924 Mary Ave after August 4^th.If you have any questions please email info@leebio.com

Burton Lee

 CEO

MARYLAND HEIGHTS, MO    / Lee Biosolutions is proud to announce that it has an exclusive Clinical Trail Supply Agreement with St. Teresa Medical, Inc. to support their SURGICLOT(R) Haemostatic Dressing. Lee Biosolutions' scientific team's extensive expertise with coagulation factors such as Human Thrombin and Fibrinogen made it an ideal partner to meet Saint Teresa Medical's requirements. St. Teresa Medical is a medical device company commercializing a new haemostatic technology platform.

Lee Biosolutions partnership with St. Teresa Medical ,covers the process development and manufacture of bulk cGMP Human Fibrinogen and Thrombin, analytical support and testing services, analytical methods development and validation, stability testing and viral clearance management. St. Teresa Medical owns the analytical methods and validation processes as a result of our close collaboration.

Burton Lee, CEO "St. Teresa Medical is an innovator in the market place and we are very proud that they chose Lee Biosolutions as a key supplier for this novel (or cutting edge) technology."

About Lee Biosolutions, Inc.:

We are headquartered in a 41,000 square feet state of the art cGMP-compliant facility in Maryland Heights, MO. Lee Biosolutions is a certified, licensed ISO, FDA, EPA and USDA leader in process development and bulk manufacturing of high quality purified enzymes and related proteins for research and clinical diagnostic tests. Lee Biosolutions products are used for such pathologies as cardiac disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders

Lee Biosolutions’ facility is registered with the FDA. These products are produced in accordance with the FDA’s “Guidance for Industry: cGMP for Phase 1 Investigational Drugs” and Q7A, Section 19: “APIs for Use in Clinical Trials”.

On April 1^st at the Great Circle Edgewood Campus in Webster Groves, Lee Biosolutions was one of seven recipients that was recognized with the 2015 Circle of Caring Volunteer Award. Lee Biosolutions was recognized by developing a highly specialized alternative internship program specifically designed for the older youth attending Hitchcock school at the Edgewood Campus.

Great Circle provides advance residential treatment for children with autism, respite services, self-injury treatment, behavioral healthcare, foster care and a place for middle and upper school students at Hitchcock School who are not able to function in a traditional education setting. Lee Biosolutions has continued through the years to be involved with community volunteerism and continues  coming up with innovative ways to be able to give back to those in need.

Burton Lee, President and CEO, “It has been one of the most fulfilling experiences to customize a program that benefits the Youth by equipping them with additional skills and knowledge by being part of the LeeBio team . We design the job around the priorities of the student, family and counselors which is unique in our field. They will finish the program with a sense of pride and  can to look back and see what they have been able to accomplish. These are students that others have given up on. We never will.  “

About Lee Bio

Lee Biosolutions is a manufacturer of high purity finished enzymes and related proteins such as cardiac and tumor biomarkers used by research institutions, IVD manufacturers and the biotech healthcare industries worldwide. LeeBio is known for its expertise, leadership and support by clients because of the its ability to partner with them in the development, purification, scale up and commercialization of innovative products.